E-ISSN: 2791-8823
COVID-19 Vaccines [Cam Sakura Med J]
Cam Sakura Med J. 2023; 3(3): 86-90 | DOI: 10.4274/csmedj.galenos.2022.2022-11-5

COVID-19 Vaccines

Sibel Yıldız Kaya1, Abdurrahman Kaya2, Birgül Mete1
1İstanbul University-Cerrahpaşa, Cerrahpaşa Faculty of Medicine, Department of Infectious Disease and Clinical Microbiology, İstanbul, Turkey
2İstanbul Training and Research Hospital, Clinic of Infectious Disease and Clinical Microbiology, İstanbul, Turkey

The novel coronavirus is an infectious disease caused by severe acute respiratory syndrome coronavirus-2. The World Health Organization declared coronavirus disease-2019 (COVID-19) outbreak is a pandemic in 2020. Many people die of acute respiratory failure both in community and hospital. Therefore, there is an urgent need for a novel effective treatment or vaccine to combat the outbreak. To develop new vaccine, a wide variety of studies have been conducted in many countries. Some vaccines are approved by the Food and Drug Administration. They were developed by a vari-ety of techniques; mRNA, inactivated, recombinant and vector-based vaccines. Most of them are safe and effective, but some adverse reactions have been observed. COVID-19 vaccination prevented spread of the virus and halted the outbreak, by breaking the chain of the infection. Thus, the pan-demic has proven again that vaccination is essential for human health. In this article, we attempted to review the commonly used ones in clinical practice.

Keywords: Coronavirus, COVID-19, pandemic, vaccines

Sibel Yıldız Kaya, Abdurrahman Kaya, Birgül Mete. COVID-19 Vaccines. Cam Sakura Med J. 2023; 3(3): 86-90

Corresponding Author: Sibel Yıldız Kaya, Türkiye
Manuscript Language: English
LookUs & Online Makale